118th Congress · HOUSE BILLBILL

H.R. 71 — Medical Innovation Acceleration Act of 2023

“To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.”

Health

Introduced Jan 9, 2023

Last action Jan 9, 2023

Pipeline · Bill → Law

Step 1

Introduced

Jan 9, 2023

Step 2

Referred

Jan 9, 2023

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Jan 9, 2023

Introduced in House

Jan 9, 2023

Referred to the Subcommittee on Health.

Jan 9, 2023

Referred to the House Committee on Energy and Commerce.